{"transactions":[{"id":1128917,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-30T20:17:55.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":11700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":11700,"derivative":{"exercise_price":1.39,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":11700},"source":{"system":"sec-edgar","filing":"0001062993-25-010576","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299325010576/form4.xml","form_type":"4"}},{"id":1128916,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T20:17:55.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":7950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":18470,"source":{"system":"sec-edgar","filing":"0001062993-25-010576","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299325010576/form4.xml","form_type":"4"}},{"id":1488085,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T21:00:31.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of (a) June 4, 2025, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":6200,"derivative":{"exercise_price":5.71,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":6200},"source":{"system":"sec-edgar","filing":"0001062993-24-012091","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299324012091/form4.xml","form_type":"4"}},{"id":1488084,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T21:00:31.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest on the earlier of (a) June 4, 2025, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":10520,"source":{"system":"sec-edgar","filing":"0001062993-24-012091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299324012091/form4.xml","form_type":"4"}},{"id":1869126,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T20:37:29.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":5360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5360,"derivative":{"exercise_price":10.34,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":5360},"source":{"system":"sec-edgar","filing":"0001062993-23-012776","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299323012776/form4.xml","form_type":"4"}},{"id":1869125,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T20:37:29.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":3135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest on the earlier of (a) June 1, 2024, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":6270,"source":{"system":"sec-edgar","filing":"0001062993-23-012776","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299323012776/form4.xml","form_type":"4"}},{"id":2246999,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-02T20:04:55.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":5360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of (a) June 1, 2023, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Peron's continued service through the applicable vesting date."}],"balance_after":5360,"derivative":{"exercise_price":6.84,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":5360},"source":{"system":"sec-edgar","filing":"0001062993-22-014126","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299322014126/form4.xml","form_type":"4"}},{"id":2246998,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T20:04:55.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":3135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest on the earlier of (a) June 1, 2023, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Peron's continued service through the applicable vesting date."}],"balance_after":3135,"source":{"system":"sec-edgar","filing":"0001062993-22-014126","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000106299322014126/form4.xml","form_type":"4"}},{"id":2680473,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T20:55:14.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":10825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 2, 2022, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":10825,"derivative":{"exercise_price":13.16,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":10825},"source":{"system":"sec-edgar","filing":"0001192482-21-000490","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248221000490/edgar.xml","form_type":"4"}},{"id":3118138,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-08T20:37:56.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":8806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) the first anniversary of June 4, 2020, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan), subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8806,"derivative":{"exercise_price":17,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":8806},"source":{"system":"sec-edgar","filing":"0001192482-20-000449","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248220000449/edgar.xml","form_type":"4"}},{"id":3372501,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":1665,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":1665,"derivative":{"exercise_price":28.65,"exercise_date":"2019-11-13","expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":67},"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372500,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":1665,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":1.16,"exercise_date":"2017-01-18","expiration_date":"2027-01-18","underlying":"Series B Preferred Stock","underlying_shares":1665},"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372499,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":123653,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":123653,"derivative":{"exercise_price":28.65,"exercise_date":"2017-11-13","expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":5008},"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372498,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":123653,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":1.16,"exercise_date":"2017-01-18","expiration_date":"2027-01-18","underlying":"Series B Preferred Stock","underlying_shares":123653},"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372497,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":72417,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2931},"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372496,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":5377928,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":217816},"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372495,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":6643,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":269},"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372494,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":493357,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":19982},"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372493,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":217816,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":498606,"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372492,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":19982,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":280790,"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372491,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":2931,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":15875,"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372490,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":269,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":12944,"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372489,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-08","kind":"purchase","acquired":true,"shares":75901,"price":13,"value":986713.0,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 183,907 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a)."}],"balance_after":260808,"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}},{"id":3372488,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":79064,"kind":"person","name":"Azarbarzin Kurt","position":1,"cik":"0001792303","reported_name":"Azarbarzin Kurt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:52:22.000Z","date":"2019-11-08","kind":"purchase","acquired":true,"shares":10220,"price":13,"value":132860.0,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 2,455 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a)."}],"balance_after":12675,"source":{"system":"sec-edgar","filing":"0001192482-19-000424","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000424/edgar.xml","form_type":"4"}}]}